DOI: 10.1128/JCM.41.10.4578-4582.2003
Article Figures & Data
Figures
- FIG. 1.
PFGE analysis of DNA isolated from human Salmonella strains (strains Snp1, Snp5, Snp6, and Snp7) and a Salmonella strain from a commercial product (strain Snp8). DNA was cleaved with the endonuclease XbaI or BlnI. Snp1, Snp5, Snp6, Snp7, and Snp8 designate the strains described in the text. Lanes M, S. enterica serotype Newport AM01144 (915 to 35.8 kb), used as a size marker. The braces indicate the restriction endonuclease used for each digestion.
Tables
- TABLE 1.
S. enterica serotype Newport strains isolated from humans in Alberta, Canada, from January 1998 to December 2002
Yr No. of Salmonella sp.a No. of Salmonella serotype Newport isolates PTsb No. of strains resistant to: AMP CAZ FOX CHL SXT 1998 1,138 9 8, 9, 14 0 0 0 0 0 1999 1,106 16 8, 9, 13, 14 0 0 0 0 0 2000 1,065 8 NT, 14 0 0 0 0 0 2001 1,244 7 3, 4, 8, 9, 10 0 0 0 0 0 2002 889 21 4, 8, 9, 10, 14, 15, 17 9 9 9 9 1 - TABLE 2.
MICs for clinical strains of S. enterica serotype Newport
Clinical straina Origin MIC (μg/ml) AMP SAM FOX CPD CAZ CTX and CROb ATM FEP CHL SXT GEN TOB AMK CIP Snp1 Patient A >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp2 Patient A >16 >16/8 >16 >8 >16 >32 >16 8 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp3 Patient A >16 >16/8 >16 >8 >16 >32 >16 8 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp4 Patient B >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp5 Patient C >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp6 Patient D >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp7 Patient E >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5 Snp8 Pet treat >16 >16/8 >16 >8 >16 16 16 ≤2 >16 ≤1/19 ≤0.25 ≤0.25 ≤1 ≤0.5
